Defiance Daily Target 2X Long IONQ ETF (IONX)

On our desk, we are closely tracking the 1-year beta of 4.81 against the broader market for IONX. This magnifies equity swings by more than four times, making it completely unsuitable for multi-month holding periods due to daily rebalancing drag and severe volatility decay.

Looking at Q2 2026 regulatory filings, institutional participation ticked up slightly with 13 hedge funds holding $9.29M and ownership rising to 3.88%. However, given that the fund trades down from its October 2025 peak near $311.87 to lows around $16.81, this positioning looks more like tactical short-term trading than any structural long-term investment conviction.

When evaluating pre-revenue quantum-computing derivatives like IONX, my primary clinical protocol is to stress-test the portfolio against high VIX regimes. With the CBOE VIX spiking near 45-50 during early spring 2026, the underlying asset's lack of meaningful earnings combined with a 1.05% expense ratio creates massive structural headwinds.

As a risk manager, I note that short interest in IONX dropped by 52.86% as of June 30, 2026, down to 160,865 shares, representing a days-to-cover ratio of just 0.2 days. Despite a subsequent 78.3% blip in short interest reported by August, the liquidity profile remains erratic and tightly bound to IONQ's daily price action.

In our options structuring sessions, we observed that funds held more call options than puts during Q2 2026. Even so, traders must remember the fund's own warning: it should not be expected to provide two times the cumulative return of IONQ for periods greater than a single trading day.